Log In
Print
BCIQ
Print
Print this Print this
 

CUDC-907

  Manage Alerts
Collapse Summary General Information
Company Curis Inc.
DescriptionDual phosphoinositide 3-kinase (PI3K) and histone deacetylase (HDAC) inhibitor
Molecular Target Phosphoinositide 3-kinase (PI3K) ; Histone deacetylase (HDAC)
Mechanism of ActionHistone deacetylase (HDAC) inhibitor; Phosphoinositide 3-kinase (PI3K) inhibitor
Latest Stage of DevelopmentPhase I
IndicationMultiple myeloma (MM)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today